CPT code 41105 denotes a surgical excision of tissue from the posterior one third of the tongue for biopsy. This code captures a focused diagnostic procedure used when tissue from the base or posterior tongue is required to establish a histologic diagnosis. Nationally, accurate coding for this procedure matters for claims processing, quality measurement, and appropriate tracking of head and neck diagnostic services.

Key payers in typical coverage discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find practical benchmarks and clinical context for code use, including common service locations and the clinical rationale for posterior tongue biopsy. The publication outlines billing and documentation considerations relevant to payers listed above and highlights typical payer coverage patterns and authorization touchpoints.

This analysis provides: a concise description of the procedure and when it is used; expected sites of service; alignment with commonly billed head and neck surgical services; and a national perspective on how payers approach coverage and claims adjudication for this diagnostic excision. Data not available in the input is noted where specific payer policy details, associated taxonomies, and ICD-10 diagnosis pairings would normally be included.